Recon: CVS launches biosimilar subsidiary Cordavis; White House set to identify initial 10 drugs for Medicare negotiations

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy